Step by Stepa HemeOncBuddy patient portal

HiDAC

Illustration: HiDAC

Say it: HIGH-dack

High dose cytarabine, with or without midostaurin

HiDAC means high doses of the chemotherapy cytarabine, given to people with acute myeloid leukemia (AML) after the first treatment has put the leukemia into remission.

Also called: High dose cytarabine, HDAC, High dose Ara-C, HiDAC consolidation, HiDAC with midostaurin, Intermediate dose cytarabine (IDAC)

What it is

After the first treatment (often 7+3) clears the leukemia from the blood and bone marrow, a few hidden leukemia cells usually remain. HiDAC is given in several rounds to wipe out these remaining cells. The goal is cure, or to keep the leukemia away long enough to move to a stem cell transplant if one is planned.

Hihigh
Ddose
ACAra-C (cytarabine)

Often used for

HiDAC alone
Used after remission for many people with AML, especially those with favorable gene changes (such as core binding factor AML).
HiDAC with midostaurin
For AML with a FLT3 gene change. Midostaurin capsules are taken after the cytarabine part of each cycle to target the FLT3 signal that helps the leukemia grow.

The medicines in this plan

Cytarabine (Ara-C)
Chemotherapy that stops leukemia cells from copying their DNA. Given through a vein over about 3 hours, often every 12 hours on days 1, 3 and 5.
Midostaurin
Only for AML with a FLT3 gene change. A capsule taken by mouth twice a day with food, usually on days 8 to 21 of each cycle.

How you get it

HiDAC may be given in the hospital or, at some centers, in an outpatient clinic with very close follow up. Each round of cytarabine takes about 5 days, and then you recover while blood counts drop and come back up. Rounds are usually given about every 4 to 5 weeks, for 3 to 4 rounds in total. Your schedule may be different.

A typical cycle

Days 1 to 5
Cytarabine through a vein, often every 12 hours on days 1, 3 and 5. Steroid eye drops are started to protect your eyes. Your nurse checks your balance, speech and handwriting before each dose.
Days 8 to 21
Midostaurin capsules twice a day, if your AML has a FLT3 change.
Days 7 to 25
Blood counts are low. You may need blood or platelet transfusions and infection prevention medicines. Many people come to the clinic 2 to 3 times a week for blood tests.
Days 25 to 35
Counts recover, and the next round starts once they are high enough.

Common side effects and what helps

Call your care team right away if you have

Good to know

At home

Questions to ask

Leukemia

Sources

Quick answers

What is HiDAC?
HiDAC means high doses of the chemotherapy cytarabine, given to people with acute myeloid leukemia (AML) after the first treatment has put the leukemia into remission. High dose cytarabine, with or without midostaurin.
What does HiDAC stand for?
Hi = high; D = dose; AC = Ara-C (cytarabine).
How is HiDAC given?
HiDAC may be given in the hospital or, at some centers, in an outpatient clinic with very close follow up. Each round of cytarabine takes about 5 days, and then you recover while blood counts drop and come back up. Rounds are usually given about every 4 to 5 weeks, for 3 to 4 rounds in total. Your schedule may be different.
What are the common side effects of HiDAC?
Very low blood counts for 1 to 3 weeks, with high infection risk. Red, gritty or sore eyes. Nausea and vomiting. Tiredness. Fever or rash during the days cytarabine is given. Mouth sores. Easy bruising or bleeding from low platelets. With midostaurin: nausea, vomiting and headache.
When should I call my care team during HiDAC?
A fever of 100.4 degrees Fahrenheit (38 degrees Celsius) or higher, or chills; New trouble walking, poor balance, slurred speech, shaky hands or messy handwriting; Bleeding that will not stop, blood in urine or stool, or many new bruises; Trouble breathing or chest pain; Eye pain or a change in vision; Vomiting so much you cannot keep fluids or medicines down; Feeling very weak, dizzy or confused.

Last updated: 2026-10-27. Medically reviewed by Veli Bakalov, MD, medical oncologist (October 2026). General education from Step by Step, the patient portal of HemeOncBuddy.